NCT07482969 Prevalence of Symptomatic Gastroesophageal Reflux Disease in Czech Children (Czech GERDKids)
| NCT ID | NCT07482969 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Motol |
| Condition | Gastro Esophageal Reflux |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-12-20 |
| Primary Completion | 2028-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2025-12-20 with a primary completion date of 2028-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to determine the prevalence of symptomatic gastroesophageal reflux disease (GERD) in children aged 8-9 years and 12-13 years in the Czech Republic. Participants are recruited through schools and complete a web-based questionnaire assessing reflux-related symptoms. Children reporting pyrosis or regurgitation undergo a stepwise diagnostic evaluation that includes a standardized proton pump inhibitor (PPI) trial, upper endoscopy when indicated, and 24-hour pH-impedance monitoring for those with inconclusive findings. These procedures allow classification into confirmed GERD, reflux hypersensitivity, or functional pyrosis. All children undergoing diagnostic testing complete a validated quality-of-life questionnaire. The study will provide population-based prevalence estimates and evaluate symptom burden and potential risk factors associated with pediatric GERD.
Eligibility Criteria
Inclusion Criteria: * age group of 8 - 9 years and 12 - 13 years * school attendance ability Exclusion Criteria: * psychomotor impairment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07482969 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 13 Years, studying Gastro Esophageal Reflux. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07482969 currently recruiting?
Yes, NCT07482969 is actively recruiting participants. Contact the research team at terezadrskova@gmail.com for enrollment information.
Where is the NCT07482969 trial being conducted?
This trial is being conducted at Prague, Czechia.
Who is sponsoring the NCT07482969 clinical trial?
NCT07482969 is sponsored by University Hospital, Motol. The trial plans to enroll 1,000 participants.